US scientists uses artificial enzymes to counter cytokine storm in Coronavirus patients... Jul 03
EUSA Pharma, FDA approval of phase 3 clinical trial for Siltuximab in patients with COVID-19 associated Acute Respiratory Distress Syndrome ... Jul 03
-Advertisements-